Alternative Polyadenylation Regulation in Cardiac Development and Cardiovascular Disease

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2023 Jan 19

PMID 36657944

Authors

Jun Cao

Muge N Kuyumcu-Martinez

Affiliations

Soon will be listed here.

Abstract

Cleavage and polyadenylation of pre-mRNAs is a necessary step for gene expression and function. Majority of human genes exhibit multiple polyadenylation sites, which can be alternatively used to generate different mRNA isoforms from a single gene. Alternative polyadenylation (APA) of pre-mRNAs is important for the proteome and transcriptome landscape. APA is tightly regulated during development and contributes to tissue-specific gene regulation. Mis-regulation of APA is linked to a wide range of pathological conditions. APA-mediated gene regulation in the heart is emerging as a new area of research. Here, we will discuss the impact of APA on gene regulation during heart development and in cardiovascular diseases. First, we will briefly review how APA impacts gene regulation and discuss molecular mechanisms that control APA. Then, we will address APA regulation during heart development and its dysregulation in cardiovascular diseases. Finally, we will discuss pre-mRNA targeting strategies to correct aberrant APA patterns of essential genes for the treatment or prevention of cardiovascular diseases. The RNA field is blooming due to advancements in RNA-based technologies. RNA-based vaccines and therapies are becoming the new line of effective and safe approaches for the treatment and prevention of human diseases. Overall, this review will be influential for understanding gene regulation at the RNA level via APA in the heart and will help design RNA-based tools for the treatment of cardiovascular diseases in the future.

Citing Articles

Use of polyadenosine tail mimetics to enhance mRNA expression from genes associated with haploinsufficiency disorders.

Torkzaban B, Zhu Y, Lopez C, Alexander J, Ma J, Sun Y Mol Ther Nucleic Acids. 2025; 36(1):102453.

PMID: 39967850 PMC: 11834087. DOI: 10.1016/j.omtn.2025.102453.

Coupling of alternative splicing and alternative polyadenylation.

Zhang X, Liu F, Zhou Y Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):22-32.

PMID: 39632657 PMC: 11802343. DOI: 10.3724/abbs.2024211.

RNA binding proteins as mediators of pathological cardiac remodeling.

Acharya P, Parkins S, Tranter M Front Cell Dev Biol. 2024; 12():1368097.

PMID: 38818408 PMC: 11137256. DOI: 10.3389/fcell.2024.1368097.

RNA binding proteins in cardiovascular development and disease.

Verma S, Kuyumcu-Martinez M Curr Top Dev Biol. 2024; 156:51-119.

PMID: 38556427 PMC: 11896630. DOI: 10.1016/bs.ctdb.2024.01.007.

Deciphering Estrus Expression in Gilts: The Role of Alternative Polyadenylation and LincRNAs in Reproductive Transcriptomics.

Liu M, Chen J, Zhang C, Liu S, Chao X, Yang H Animals (Basel). 2024; 14(5).

PMID: 38473176 PMC: 10931002. DOI: 10.3390/ani14050791.

References

Di Giammartino D, Nishida K, Manley J . Mechanisms and consequences of alternative polyadenylation. Mol Cell. 2011; 43(6):853-66. PMC: 3194005. DOI: 10.1016/j.molcel.2011.08.017. View

Wang L, Zhang H, Hasim A, Tuerhong A, Hou Z, Abdurahmam A . Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells. Med Sci Monit. 2017; 23:2382-2390. PMC: 5446977. DOI: 10.12659/msm.903380. View

Masamha C, Xia Z, Yang J, Albrecht T, Li M, Shyu A . CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature. 2014; 510(7505):412-6. PMC: 4128630. DOI: 10.1038/nature13261. View

Nimura K, Yamamoto M, Takeichi M, Saga K, Takaoka K, Kawamura N . Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development. Elife. 2016; 5. PMC: 4982761. DOI: 10.7554/eLife.16030. View

Chatrikhi R, Mallory M, Gazzara M, Agosto L, Zhu W, Litterman A . RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery. Cell Rep. 2019; 28(11):2795-2806.e3. PMC: 6752737. DOI: 10.1016/j.celrep.2019.08.022. View

Srikantan S, Tominaga K, Gorospe M . Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci. 2012; 13(4):372-9. PMC: 3535178. DOI: 10.2174/138920312801619394. View

Martinez N, Su A, Burns M, Nussbacher J, Schaening C, Sathe S . Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing. Mol Cell. 2022; 82(3):645-659.e9. PMC: 8859966. DOI: 10.1016/j.molcel.2021.12.023. View

Park H, Ji P, Kim S, Xia Z, Rodriguez B, Li L . 3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk. Nat Genet. 2018; 50(6):783-789. PMC: 6689271. DOI: 10.1038/s41588-018-0118-8. View

Chang J, Yeh H, Yong J . Alternative Polyadenylation in Human Diseases. Endocrinol Metab (Seoul). 2017; 32(4):413-421. PMC: 5744726. DOI: 10.3803/EnM.2017.32.4.413. View

10.

Tyser R, Miranda A, Chen C, Davidson S, Srinivas S, Riley P . Calcium handling precedes cardiac differentiation to initiate the first heartbeat. Elife. 2016; 5. PMC: 5059139. DOI: 10.7554/eLife.17113. View

11.

Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F . Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002; 8(8):831-40. DOI: 10.1038/nm731. View

12.

Schwich O, Blumel N, Keller M, Wegener M, Setty S, Brunstein M . SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels. Genome Biol. 2021; 22(1):82. PMC: 7948361. DOI: 10.1186/s13059-021-02298-y. View

13.

Mandel C, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley J . Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature. 2006; 444(7121):953-6. PMC: 3866582. DOI: 10.1038/nature05363. View

14.

Rigo F, Martinson H . Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol. 2007; 28(2):849-62. PMC: 2223410. DOI: 10.1128/MCB.01410-07. View

15.

Schek N, Cooke C, Alwine J . Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses. Mol Cell Biol. 1992; 12(12):5386-93. PMC: 360476. DOI: 10.1128/mcb.12.12.5386-5393.1992. View

16.

Gruber A, Zavolan M . Alternative cleavage and polyadenylation in health and disease. Nat Rev Genet. 2019; 20(10):599-614. DOI: 10.1038/s41576-019-0145-z. View

17.

Masamha C, Wagner E . The contribution of alternative polyadenylation to the cancer phenotype. Carcinogenesis. 2017; 39(1):2-10. DOI: 10.1093/carcin/bgx096. View

18.

Schafer P, Tuting C, Schonemann L, Kuhn U, Treiber T, Treiber N . Reconstitution of mammalian cleavage factor II involved in 3' processing of mRNA precursors. RNA. 2018; 24(12):1721-1737. PMC: 6239180. DOI: 10.1261/rna.068056.118. View

19.

Xia Z, Donehower L, Cooper T, Neilson J, Wheeler D, Wagner E . Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nat Commun. 2014; 5:5274. PMC: 4467577. DOI: 10.1038/ncomms6274. View

20.

Schevzov G, Whittaker S, Fath T, Lin J, Gunning P . Tropomyosin isoforms and reagents. Bioarchitecture. 2011; 1(4):135-164. PMC: 3210517. DOI: 10.4161/bioa.1.4.17897. View